Bone Marrow Regulatory T Cells Are a Unique Population, Supported by Niche-Specific Cytokines and Plasmacytoid Dendritic Cells, and Required for Chronic Graft-Versus-Host Disease Control.

Saved in:
Bibliographic Details
Title: Bone Marrow Regulatory T Cells Are a Unique Population, Supported by Niche-Specific Cytokines and Plasmacytoid Dendritic Cells, and Required for Chronic Graft-Versus-Host Disease Control.
Authors: Nicholls J; Division of Blood and Marrow Transplant and Cellular Therapies, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States., Cao B; Biomedical Manufacturing Commonwealth Scientific and Industrial Research Organization, Melbourne, VIC, Australia.; Australian Regenerative Medicine Institute, Monash University, Melbourne, VIC, Australia., Le Texier L; Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Xiong LY; Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Hunter CR; Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Llanes G; Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Aguliar EG; Division of Blood and Marrow Transplant and Cellular Therapies, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States., Schroder WA; Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Phipps S; Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Lynch JP; Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Cao H; Biomedical Manufacturing Commonwealth Scientific and Industrial Research Organization, Melbourne, VIC, Australia.; Australian Regenerative Medicine Institute, Monash University, Melbourne, VIC, Australia., Heazlewood SY; Biomedical Manufacturing Commonwealth Scientific and Industrial Research Organization, Melbourne, VIC, Australia.; Australian Regenerative Medicine Institute, Monash University, Melbourne, VIC, Australia., Williams B; Biomedical Manufacturing Commonwealth Scientific and Industrial Research Organization, Melbourne, VIC, Australia.; Australian Regenerative Medicine Institute, Monash University, Melbourne, VIC, Australia., Clouston AD; Envoi Specialist Pathologists, Brisbane, QLD, Australia., Nefzger CM; Australian Regenerative Medicine Institute, Monash University, Melbourne, VIC, Australia.; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.; Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia., Polo JM; Australian Regenerative Medicine Institute, Monash University, Melbourne, VIC, Australia.; Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia.; Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC, Australia., Nilsson SK; Biomedical Manufacturing Commonwealth Scientific and Industrial Research Organization, Melbourne, VIC, Australia.; Australian Regenerative Medicine Institute, Monash University, Melbourne, VIC, Australia., Blazar BR; Division of Blood and Marrow Transplant and Cellular Therapies, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States., MacDonald KPA; Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Source: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2021 Sep 22; Vol. 9, pp. 737880. Date of Electronic Publication: 2021 Sep 22 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2296-634X
DOI:10.3389/fcell.2021.737880